The trademark application MAVCERTIX was filed by X4 Pharmaceuticals, Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on February 17, 2021, and it was registered by office on May 27, 2021 without any oppositions.
The application was filed in English (French was selected as the second language).